A COMPARATIVE-STUDY BETWEEN 100MG ATENOLOL AND 20MG PINDOLOL SLOW-RELEASE IN ESSENTIAL-HYPERTENSION

被引：23

作者：

GREMINGER, P

VETTER, H

BOERLIN, HJ

HAVELKA, J

BAUMGART, P

WALGER, P

LUSCHER, T

SIEGENTHALER, W

VETTER, W

机构：

[1] UNIV HOSP ZURICH,DEPT INTERNAL MED,CH-8091 ZURICH,SWITZERLAND

[2] UNIV MUNSTER,MED POLIKLIN,D-4400 MUNSTER,FED REP GER

来源：

DRUGS | 1983年 / 25卷

关键词：

D O I：

10.2165/00003495-198300252-00008

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：37 / 41

页数：5

共 28 条

[1]

ABERG H, 1974, NEW ENGL J MED, V290, P1026

[2]

AMERY A, 1974, NEW ENGL J MED, V290, P284

[3] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J].

BUHLER, FR ;

BRUNNER, HR ;

BAER, L ;

VAUGHAN, ED ;

LARAGH, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) :1209-+

[4] ANTIHYPERTENSIVE BETA-BLOCKING ACTION AS RELATED TO RENIN AND AGE - PHARMACOLOGIC TOOL TO IDENTIFY PATHOGENETIC MECHANISMS IN ESSENTIAL HYPERTENSION [J].

BUHLER, FR ;

BURKART, F ;

LUTOLD, BE ;

KUNG, M ;

MARBET, G ;

PFISTERER, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1975, 36 (05) :653-669

[5] ANTIHYPERTENSIVE ACTION OF PROPRANOLOL - SPECIFIC ANTIRENIN RESPONSES IN HIGH AND NORMAL RENIN FORMS OF ESSENTIAL, RENAL, RENOVASCULAR AND MALIGNANT HYPERTENSION [J].

BUHLER, FR ;

LARAGH, JH ;

VAUGHAN, ED ;

BRUNNER, HR ;

GAVRAS, H ;

BAER, L .

AMERICAN JOURNAL OF CARDIOLOGY, 1973, 32 (04) :511-522

[6]

CONWAY J, 1975, CENTRAL ACTION DRUGS, P277

[7] THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS [J].

CRUICKSHANK, JM .

AMERICAN HEART JOURNAL, 1980, 100 (02) :160-178

[8] ONCE-DAILY DOSING WITH ATENOLOL IN PATIENTS WITH MILD OR MODERATE HYPERTENSION [J].

DOUGLASJONES, AP ;

CRUICKSHANK, JM .

BRITISH MEDICAL JOURNAL, 1976, 1 (6016) :990-991

[9] CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .3. COMPARATIVE CLINICAL-EXPERIENCE AND NEW THERAPEUTIC APPLICATIONS [J].

FRISHMAN, W ;

SILVERMAN, R .

AMERICAN HEART JOURNAL, 1979, 98 (01) :119-131

[10] CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .1. PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES [J].

FRISHMAN, W .

AMERICAN HEART JOURNAL, 1979, 97 (05) :663-670

← 1 2 3 →